A study of the WNT/β-catenin regulatory mechanisms and development of ovatodiolide as a novel targeting compound in renal cell carcinoma

by Jar Yi Ho, 何嘉益
Published 2013

Improvements on Complexity Reduction Analysis for Gene Expression and Vector System for Trapping cDNA Sequences with an Open Translational Frame

by Jar-Yi Ho, 何嘉益
Published 2000

miR-429 expression in bladder cancer and its correlation with tumor behavior and clinical outcome

by Chia-Lun Wu, Jar-Yi Ho, Shun-Hsing Hung, Dah-Shyong Yu
Published 2018-06-01

Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells

by Cheng-Shuo Huang, Jar-Yi Ho, Jung-Hwa Chiang, Cheng-Ping Yu, Dah-Shyong Yu
Published 2020-06-01

Decreased drug resistance of bladder cancer using phytochemicals treatment

by Chun‐Jung Cho, Cheng‐Ping Yu, Chia‐Lun Wu, Jar‐Yi Ho, Ching‐Wei Yang, Dah‐Shyong Yu
Published 2021-02-01

Amongst Women Stratified to Receive Endocrine Therapy on the Basis of Their Tumor Estrogen and Progesterone Receptor Levels, Those with Higher Tumor Progesterone Receptor Levels Ha...

by Tai-Han Lin, Hong-Wei Gao, Guo-Shiou Liao, Jyh-Cherng Yu, Ming-Shen Dai, Jar-Yi Ho, Cheng-Ping Yu
Published 2021-02-01

Ovatodiolide Targets β-Catenin Signaling in Suppressing Tumorigenesis and Overcoming Drug Resistance in Renal Cell Carcinoma

by Jar-Yi Ho, Ren-Jun Hsu, Chieh-Lin Wu, Wen-Liang Chang, Tai-Lung Cha, Dah-Shyong Yu, Cheng-Ping Yu
Published 2013-01-01

Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters

by Ying-Si Wu, Jar-Yi Ho, Cheng-Ping Yu, Chun-Jung Cho, Chia-Lun Wu, Cheng-Shuo Huang, Hong-Wei Gao, Dah-Shyong Yu
Published 2021-04-01

Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.

by Cheng-Ping Yu, Jar-Yi Ho, Yi-Ting Huang, Tai-Lung Cha, Guang-Huan Sun, Dah-Shyong Yu, Fung-Wei Chang, Shu-Pin Chen, Ren-Jun Hsu
Published 2013-01-01

WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.

by Ren-Jun Hsu, Jar-Yi Ho, Tai-Lung Cha, Dah-Shyong Yu, Chieh-Lin Wu, Wei-Ping Huang, Pauling Chu, Ying-Hsin Chen, Jiann-Torng Chen, Cheng-Ping Yu
Published 2012-01-01

Estrogen Enhances the Cell Viability and Motility of Breast Cancer Cells through the ERα-ΔNp63-Integrin β4 Signaling Pathway.

by Jar-Yi Ho, Fung-Wei Chang, Fong Shung Huang, Jui-Ming Liu, Yueh-Ping Liu, Shu-Pin Chen, Yung-Liang Liu, Kuan-Chen Cheng, Cheng-Ping Yu, Ren-Jun Hsu
Published 2016-01-01